These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30827343)

  • 21. Drug transporter expression profiling in a three-dimensional kidney proximal tubule in vitro nephrotoxicity model.
    Diekjürgen D; Grainger DW
    Pflugers Arch; 2018 Sep; 470(9):1311-1323. PubMed ID: 29744639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved Ocular Tissue Models and Eye-On-A-Chip Technologies Will Facilitate Ophthalmic Drug Development.
    Wright CB; Becker SM; Low LA; Tagle DA; Sieving PA
    J Ocul Pharmacol Ther; 2020; 36(1):25-29. PubMed ID: 31166829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kidney-on-a-Chip Technology for Drug-Induced Nephrotoxicity Screening.
    Wilmer MJ; Ng CP; Lanz HL; Vulto P; Suter-Dick L; Masereeuw R
    Trends Biotechnol; 2016 Feb; 34(2):156-170. PubMed ID: 26708346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Technology Transfer of the Microphysiological Systems: A Case Study of the Human Proximal Tubule Tissue Chip.
    Sakolish C; Weber EJ; Kelly EJ; Himmelfarb J; Mouneimne R; Grimm FA; House JS; Wade T; Han A; Chiu WA; Rusyn I
    Sci Rep; 2018 Oct; 8(1):14882. PubMed ID: 30291268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human reconstructed kidney models.
    Kishi S; Matsumoto T; Ichimura T; Brooks CR
    In Vitro Cell Dev Biol Anim; 2021 Feb; 57(2):133-147. PubMed ID: 33594607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models.
    Tiong HY; Huang P; Xiong S; Li Y; Vathsala A; Zink D
    Mol Pharm; 2014 Jul; 11(7):1933-48. PubMed ID: 24502545
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery.
    Benedetti V; Brizi V; Guida P; Tomasoni S; Ciampi O; Angeli E; Valbusa U; Benigni A; Remuzzi G; Xinaris C
    EBioMedicine; 2018 Jul; 33():253-268. PubMed ID: 30049385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 3-D organoid kidney culture model engineered for high-throughput nephrotoxicity assays.
    Astashkina AI; Mann BK; Prestwich GD; Grainger DW
    Biomaterials; 2012 Jun; 33(18):4700-11. PubMed ID: 22444643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems.
    Pamies D; Bal-Price A; Chesné C; Coecke S; Dinnyes A; Eskes C; Grillari R; Gstraunthaler G; Hartung T; Jennings P; Leist M; Martin U; Passier R; Schwamborn JC; Stacey GN; Ellinger-Ziegelbauer H; Daneshian M
    ALTEX; 2018; 35(3):353-378. PubMed ID: 29697851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief Overview: Assessment of Compound-induced Acute Kidney Injury Using Animal Models, Biomarkers, and In Vitro Platforms.
    McDuffie JE
    Toxicol Pathol; 2018 Dec; 46(8):978-990. PubMed ID: 30392454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Kidney Models to Investigate Metabolism, Transport, and Toxicity of Drugs and Xenobiotics.
    Bajaj P; Chowdhury SK; Yucha R; Kelly EJ; Xiao G
    Drug Metab Dispos; 2018 Nov; 46(11):1692-1702. PubMed ID: 30076203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of biochemical and biomechanical factors on vascularization of kidney organoid-on-a-chip.
    Lee HN; Choi YY; Kim JW; Lee YS; Choi JW; Kang T; Kim YK; Chung BG
    Nano Converg; 2021 Nov; 8(1):35. PubMed ID: 34748091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kidney-on-a-Chip: Mechanical Stimulation and Sensor Integration.
    Wang D; Gust M; Ferrell N
    Sensors (Basel); 2022 Sep; 22(18):. PubMed ID: 36146238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human brain organoid-on-a-chip to model prenatal nicotine exposure.
    Wang Y; Wang L; Zhu Y; Qin J
    Lab Chip; 2018 Mar; 18(6):851-860. PubMed ID: 29437173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developing in vitro assays to transform gastrointestinal safety assessment: potential for microphysiological systems.
    Peters MF; Choy AL; Pin C; Leishman DJ; Moisan A; Ewart L; Guzzie-Peck PJ; Sura R; Keller DA; Scott CW; Kolaja KL
    Lab Chip; 2020 Apr; 20(7):1177-1190. PubMed ID: 32129356
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nephron organoids derived from human pluripotent stem cells model kidney development and injury.
    Morizane R; Lam AQ; Freedman BS; Kishi S; Valerius MT; Bonventre JV
    Nat Biotechnol; 2015 Nov; 33(11):1193-200. PubMed ID: 26458176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of kidney tubular organoids from human pluripotent stem cells.
    Yamaguchi S; Morizane R; Homma K; Monkawa T; Suzuki S; Fujii S; Koda M; Hiratsuka K; Yamashita M; Yoshida T; Wakino S; Hayashi K; Sasaki J; Hori S; Itoh H
    Sci Rep; 2016 Dec; 6():38353. PubMed ID: 27982115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods.
    Kandasamy K; Chuah JK; Su R; Huang P; Eng KG; Xiong S; Li Y; Chia CS; Loo LH; Zink D
    Sci Rep; 2015 Jul; 5():12337. PubMed ID: 26212763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making a Kidney Organoid Using the Directed Differentiation of Human Pluripotent Stem Cells.
    Takasato M; Little MH
    Methods Mol Biol; 2017; 1597():195-206. PubMed ID: 28361319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.